Trial Profile
Safety and efficacy of S 38093 and donepezil, during 4 weeks, in patients with mild to moderate Alzheimer's Disease. An international, multi-centre, randomised, double-blind, placebo controlled, phase II add-on study. [Seguridad y eficacia de S 38093 y donepezilo, en pacientes con enfermedad de Alzheimer leve a moderada, durante 4 semanas. Estudio de fase II, de asociación, internacional, multicéntrico, aleatorizado, doble ciego, controlado frente a placebo].
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Jun 2012
Price :
$35
*
At a glance
- Drugs S 38093 (Primary) ; Donepezil
- Indications Alzheimer's disease
- Focus Adverse reactions
- 23 Jun 2012 Additional trial location (Spain) added as reported by European Clinical Trials Database.
- 08 Jun 2011 New trial record